Comments on: Jemperli (dostarlimab-gxly) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancer

Comments on: Jemperli (dostarlimab-gxly) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancer https://lifeboat.com/blog/2024/06/jemperli-dostarlimab-gxly-trial-continues-to-show-unprecedented-results-with-no-evidence-of-disease-in-100-of-patients-with-locally-advanced-mismatch-repair-deficient-dmmr-rectal-cancer Safeguarding Humanity Thu, 06 Jun 2024 03:24:27 +0000 hourly 1 https://wordpress.org/?v=6.5.3